TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 40 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,314 | -38.8% | 13,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,783 | -84.6% | 13,000 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $24,570 | +26.8% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $19,370 | -12.0% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | -15.4% | 13,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $26,000 | -23.5% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -5.6% | 13,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $36,000 | -28.0% | 13,000 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $50,000 | -40.5% | 13,000 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $84,000 | -21.5% | 13,000 | 0.0% | 0.01% | -36.4% |
| Q1 2021 | $107,000 | -29.6% | 13,000 | 0.0% | 0.01% | -38.9% |
| Q4 2020 | $152,000 | +145.2% | 13,000 | +8.3% | 0.02% | +100.0% |
| Q3 2020 | $62,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $9,746,000 | 1.82% |
| Altium Capital Management LP | 785,341 | $3,039,000 | 0.80% |
| Ikarian Capital, LLC | 2,691,110 | $10,415,000 | 0.73% |
| Telemetry Investments, L.L.C. | 130,500 | $505,000 | 0.68% |
| Psagot Value Holdings Ltd. | 143,591 | $556,000 | 0.10% |
| Psagot Value Holdings Ltd. / (Israel) | 143,591 | $556,000 | 0.10% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $110,000 | 0.06% |
| X-Square Capital, LLC | 17,973 | $70,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 85,993 | $333,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 268,301 | $1,038,000 | 0.03% |